Gilead Sciences | Capitalização De Mercado



Market Capitalization Alterar Data
AbbVie USD 306.72B 7.3B 2025-04
Agios Pharmaceuticals USD 1.57B 303M 2025-04
ALKERMES USD 4.4B 252M 2025-04
Alnylam Pharmaceuticals USD 29.63B 5.49B 2025-04
Amgen USD 155.38B 15.41B 2025-04
Biogen USD 17.08B 5.2B 2025-04
BioMarin Pharmaceutical USD 11.34B 1.19B 2025-04
Bristol-Myers Squibb USD 100.66B 14.06B 2025-04
Eli Lilly USD 706.59B 26.28B 2025-04
Gilead Sciences USD 131.99B 16.9B 2025-04
GlaxoSmithKline GBP 55.34B 469.7M 2025-04
Glaxosmithkline USD 73.89B 4.07B 2025-04
Incyte USD 13.05B 253M 2025-04
J&J USD 379.47B 20.18B 2025-04
Merck USD 196.74B 54.91B 2025-04
Moderna USD 9.83B 6.17B 2025-04
Neurocrine Biosciences USD 9.87B 3.95B 2025-04
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 126.33B 24.01B 2025-04
PTC Therapeutics USD 3.43B 77M 2025-04
Regeneron Pharmaceuticals USD 60.81B 8.53B 2025-04
Sanofi EUR 118.41B 10.58B 2024-12
Sarepta Therapeutics USD 5.03B 6.76B 2025-04
United Therapeutics USD 13.39B 2.36B 2025-04
Vertex Pharmaceuticals USD 127.19B 23.74B 2025-04



Gilead Sciences Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.